UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

E.05.02 Making better early go/no-go decisions in drug development progress in the NIMH FAST-FAIL programme

European neuropsychopharmacology, 2014-10, Vol.24, p.S150-S150

Potter, W.Z

2014

Volltextzugriff (PDF)

Report of the task force on designing clinical trials in early (predementia) AD

Neurology, 2011-01, Vol.76 (3), p.280-286

2011

Volltextzugriff (PDF)

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers

Schizophrenia research, 2023-04, Vol.254, p.178-189

2023

Volltextzugriff (PDF)

Dose ranging for trials through biomarkers of drug effects

The Journal of nutrition, health & aging, 2010-04, Vol.14 (4), p.310-311

Potter, W. Z.

2010

Volltextzugriff (PDF)

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

The pharmacogenomics journal, 2010-06, Vol.10 (3), p.161-164

2010

Volltextzugriff (PDF)

274. Early clinical development of psychoactive drugs: Pro's and con's of academic collaborations

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S82-S82

Potter, W.Z.

1998

Volltextzugriff (PDF)

Future antidepressants: What is possible?

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.73S-73S

1997

Volltextzugriff (PDF)

Hormones and antidepressants: implications for new drug development

Biological psychiatry (1969), 1997-07, Vol.42 (1), p.222S-223S

1997

Volltextzugriff (PDF)

Clinical onset of antidepressant action: Implications for new drug development

European neuropsychopharmacology, 1996-06, Vol.6, p.86-87

1996

Volltextzugriff (PDF)

Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters

Pharmacology, 1974, Vol.12 (3), p.129-143

1974

Volltextzugriff (PDF)

Controlling the placebo response rates in depression

European neuropsychopharmacology, 1998-11, Vol.8, p.S80-S81

1998

Volltextzugriff (PDF)

Evidence for rating distortion during study lead-in periods: Implications for study design and outcome

European neuropsychopharmacology, 1998-11, Vol.8, p.S154

1998

Volltextzugriff (PDF)

324. Implications of a significant treatment by country interaction

Biological psychiatry (1969), 1998-04, Vol.43 (8), p.S97-S97

1998

Volltextzugriff (PDF)

Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide

Pharmacology, 1976-01, Vol.14 (3), p.205-217

1976

Volltextzugriff (PDF)

CSF homovanillic acid predicts behavioral response to stimulants in 47 ADHD boys

Biological psychiatry (1969), 1995-05, Vol.37 (9), p.644-644

1995

Volltextzugriff (PDF)

A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation

Medical hypotheses, 1989-05, Vol.29 (1), p.33-42

1989

Volltextzugriff (PDF)

Promising medications not available in the United States

Biological psychiatry (1969), 1994-05, Vol.35 (9), p.678-678

1994

Volltextzugriff (PDF)

Increased levels of Gαs in platelets of euthymic bipolar affective disorder patients

European neuropsychopharmacology, 1996-06, Vol.6, p.184-184

1996

Volltextzugriff (PDF)

Augmentation of neuroleptics with idazoxan: Focus on noradrenergic function in schizophrenia

Schizophrenia research, 1993-04, Vol.9 (2), p.242-242

1993

Volltextzugriff (PDF)

Signal transduction pathways. Molecular targets for lithium's actions

Archives of general psychiatry, 1995-07, Vol.52 (7), p.531

1995

Volltextzugriff (PDF)

Commentary on the management of treatment-resistant affective disorder: clinical perspectives

Journal of psychopharmacology (Oxford), 1992-01, Vol.6 (2), p.164-166

1992

Volltextzugriff (PDF)

Noradrenergic Function in Affective Illness

Neuro-Psychopharmacology, 1979, p.127-137

1979

Volltextzugriff (PDF)

Effects of psychotropic drugs on neurotransmitters in man

Life sciences (1973), 1987-08, Vol.41 (7), p.817-820

1987

Volltextzugriff (PDF)

Treatment of Major Depression: Selection of Initial Drug

Modern problems of pharmacopsychiatry, 1997, Vol.25, p.1-16

1997

Volltextzugriff (PDF)

Biochemical changes after hepatic injury by allyl alcohol and N-hydroxy-2-acetylaminoflourene

Chemico-biological interactions, 1976, Vol.15 (2), p.139-147

1976

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

E.05.02 Making better early go/no-go decisions in drug development progress in the NIMH FAST-FAIL programme

Report of the task force on designing clinical trials in early (predementia) AD

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers

Dose ranging for trials through biomarkers of drug effects

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

274. Early clinical development of psychoactive drugs: Pro's and con's of academic collaborations

Future antidepressants: What is possible?

Hormones and antidepressants: implications for new drug development

Clinical onset of antidepressant action: Implications for new drug development

Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters

Controlling the placebo response rates in depression

Evidence for rating distortion during study lead-in periods: Implications for study design and outcome

324. Implications of a significant treatment by country interaction

Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide

CSF homovanillic acid predicts behavioral response to stimulants in 47 ADHD boys

A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation

Promising medications not available in the United States

Increased levels of Gαs in platelets of euthymic bipolar affective disorder patients

Augmentation of neuroleptics with idazoxan: Focus on noradrenergic function in schizophrenia

Signal transduction pathways. Molecular targets for lithium's actions

Commentary on the management of treatment-resistant affective disorder: clinical perspectives

Noradrenergic Function in Affective Illness

Effects of psychotropic drugs on neurotransmitters in man

Treatment of Major Depression: Selection of Initial Drug

Biochemical changes after hepatic injury by allyl alcohol and N-hydroxy-2-acetylaminoflourene

Suchergebnisse filtern